Frank X. Leonard - 03 Mar 2026 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Executive Officer
Signature
Steven Robbins, as attorney in fact for Leonard, Frank X.
Issuer symbol
NVCR
Transactions as of
03 Mar 2026
Net transactions value
-$74,603
Form type
4
Filing time
05 Mar 2026, 16:31:35 UTC
Previous filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Leonard Frank X Chief Executive Officer C/O NOVOCURE INC., 1550 LIBERTY RIDGE DRIVE, SUITE 115, WAYNE Steven Robbins, as attorney in fact for Leonard, Frank X. 05 Mar 2026 0001822879

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Award +150,000 +43% $0.000000* 499,400 03 Mar 2026 Direct F1
transaction NVCR Ordinary Shares Sale $74,603 -5,607 -1.1% $13.31 493,793 04 Mar 2026 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Stock Option (Right to Buy) Award +216,388 $0.000000* 216,388 03 Mar 2026 Ordinary Shares 216,388 $13.30 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted share units that are scheduled to vest in equal parts on the first, second and third anniversary of the grant date, subject to the reporting person's continued employment through such dates.
F2 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F3 This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price.
F4 Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date.